Metformin for the treatment of the polycystic ovary syndrome

被引:197
|
作者
Nestler, John E.
机构
[1] Virginia Commonwealth Univ, Med Coll Virginia, Dept Internal Med, Div Endocrinol & Metab, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23298 USA
[3] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Richmond, VA 23298 USA
来源
NEW ENGLAND JOURNAL OF MEDICINE | 2008年 / 358卷 / 01期
关键词
D O I
10.1056/NEJMct0707092
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 23- year- old woman with known polycystic ovary syndrome visits her family physician. She has taken oral contraceptive pills in the past but did not tolerate them and is not currently receiving any treatment. She has three or four menstrual periods per year and is not interested in becoming pregnant now, but she will be getting married in a year. She has heard that the polycystic ovary syndrome is associated with diabetes and is concerned because both her mother and father have type 2 diabetes. Her body-mass index ( the weight in kilograms divided by the square of the height in meters) is 32, her waist circumference is 38 in. ( 96.5 cm), her serum total testosterone level is elevated at 0.9 ng per milliliter ( 90 ng per deciliter, or 2.9 nmol per liter), her plasma high- density lipoprotein cholesterol level is 35 mg per deciliter ( 0.9 mmol per liter), and her triglyceride level is 190 mg per deciliter ( 2.1 mmol per liter). Her serum glucose level 2 hours after the ingestion of 75 g of dextrose is 138 mg per deciliter ( 7.7 mmol per liter). The physician wonders whether treatment with metformin would be beneficial and refers the patient to an endocrinologist.
引用
收藏
页码:47 / 54
页数:8
相关论文
共 50 条
  • [31] Reimbursement of metformin for polycystic ovary syndrome
    Milewicz, Andrzej
    ENDOKRYNOLOGIA POLSKA, 2013, 64 (05) : 409 - 414
  • [32] Use of metformin in polycystic ovary syndrome
    Mathur, Ruchi
    Alexander, Carolyn J.
    Yano, Jacqueline
    Trivax, Bradley
    Azziz, Ricardo
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 199 (06) : 596 - 609
  • [33] Polycystic ovary syndrome and metformin in pregnancy
    Lilja, Anna E.
    Mathiesen, Elisabeth R.
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2006, 85 (07) : 861 - 868
  • [34] Effects of metformin treatment on pregnancy outcomes in patients with polycystic ovary syndrome
    Raperport, Claudia
    Chronopoulou, Elpiniki
    Homburg, Roy
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2021, 16 (02) : 37 - 47
  • [35] Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome
    Diri, Halit
    Karaburgu, Sulbiye
    Acmaz, Banu
    Unluhizarci, Kursad
    Tanriverdi, Fatih
    Karaca, Zuleyha
    Kelestimur, Fahrettin
    GYNECOLOGICAL ENDOCRINOLOGY, 2016, 32 (01) : 42 - 45
  • [36] The role of metformin in the management of polycystic ovary syndrome
    Tsilchorozidou, T
    Prelevic, GM
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2003, 15 (06) : 483 - 488
  • [37] Insulin resistance and metformin in polycystic ovary syndrome
    Ben-Haroush, A
    Yogev, Y
    Fisch, B
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2004, 115 (02) : 125 - 133
  • [38] Use of metformin for women with polycystic ovary syndrome
    Tang, Thomas
    Balen, Adam H.
    HUMAN REPRODUCTION UPDATE, 2013, 19 (01) : 1 - 1
  • [39] The effect of metformin on hirsutism in polycystic ovary syndrome
    Kelly, CJG
    Gordon, D
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2002, 147 (02) : 217 - 221
  • [40] Insulin Resistance, Polycystic Ovary Syndrome and Metformin
    Michel Pugeat
    Pierre Henri Ducluzeau
    Drugs, 1999, 58 : 41 - 46